New combo therapy tested for Hard-to-Treat blood disorder
NCT ID NCT07278908
Summary
This study is testing whether adding a vitamin A-related drug (all-trans retinoic acid) to an existing platelet-boosting medication (avatrombopag) works better for controlling immune thrombocytopenia (ITP) than the platelet medication alone. It will involve 248 adults whose ITP hasn't responded well to first treatments or has come back. Participants will be randomly assigned to receive either the single drug or the combination for up to a year to compare effectiveness and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ITP - IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.